Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ 179,421 $ (533,182)
Reconciling items:    
Depreciation 114,119 111,864
Amortization 102,277 100,457
Amortization of non-recoupable ticketing contract advances 40,392 28,728
Amortization of debt issuance costs and discounts 8,224 18,373
Stock-based compensation expense 61,741 52,847
Unrealized changes in fair value of contingent consideration 18,010 (8,040)
Equity in losses (earnings) of nonconsolidated affiliates, net of distributions 10,112 10,002
Provision for uncollectible accounts receivable 25,702 (16,563)
Gain (Loss) on Sale of Investments 448 52,947
Other, net 10,033 9,847
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Increase in accounts receivable (440,290) (143,343)
Increase in prepaid expenses and other assets (607,939) (102,554)
Increase in accounts payable, accrued expenses and other liabilities 972,906 518,810
Increase in deferred revenue 1,053,178 1,175,690
Net cash provided by operating activities 1,547,438 1,169,989
CASH FLOWS FROM INVESTING ACTIVITIES    
Advances of notes receivable (30,558) (12,830)
Collections of notes receivable 11,074 10,618
Investments made in nonconsolidated affiliates (46,699) (33,729)
Purchases of property, plant and equipment (130,278) (58,066)
Cash paid for acquisitions, net of cash acquired (39,854) (7,627)
Purchases of intangible assets (6,129) (11,191)
Proceeds from Sale of Long-term Investments 1,204 61,618
Other, net (3,496) 912
Net cash used in investing activities (244,736) (50,295)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 4,009 511,068
Payments on long-term debt (22,638) (85,125)
Contributions from noncontrolling interests 13,448 15,288
Distributions to noncontrolling interests (66,114) (14,542)
Purchases and sales of noncontrolling interests, net (27,138) (3,273)
Proceeds from exercise of stock options 26,051 28,083
Taxes paid for net share settlement of equity awards (41,731) (38,209)
Payments for deferred and contingent consideration (22,508) (11,926)
Other, net (1,014) 105
Net cash provided by (used in) financing activities (137,635) 401,469
Effect of exchange rate changes on cash, cash equivalents and restricted cash (186,703) (19,965)
Net increase in cash, cash equivalents, and restricted cash 978,364 1,501,198
Cash, cash equivalents, and restricted cash at beginning of period 4,887,792 2,546,439
Cash, cash equivalents, and restricted cash at end of period $ 5,866,156 $ 4,047,637